<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H6316CC792E1D4849A3E3DBF41B4F85DF" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 1291 IH: Stopping Overdoses of Fentanyl Analogues Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-03-01</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1291</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230301">March 1, 2023</action-date><action-desc><sponsor name-id="F000471">Mr. Fitzgerald</sponsor> (for himself, <cosponsor name-id="C001135">Mrs. Chavez-DeRemer</cosponsor>, <cosponsor name-id="T000165">Mr. Tiffany</cosponsor>, <cosponsor name-id="M000317">Ms. Malliotakis</cosponsor>, <cosponsor name-id="M001216">Mr. Mills</cosponsor>, and <cosponsor name-id="H001091">Mrs. Hinson</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.</official-title></form><legis-body id="HE706A17456EA4390A08420FDA7BDF33F" style="OLC"> 
<section id="HB6A5B94C26B441629B227B6174EDA471" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Stopping Overdoses of Fentanyl Analogues Act</short-title></quote>.</text></section> <section id="H337A36E72B3A4FB296EC4BE97A196FA0"><enum>2.</enum><header>Archie Badura Memorial Fentanyl Related Substance Scheduling</header> <text display-inline="no-display-inline">Section 202(c) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/812">21 U.S.C. 812(c)</external-xref>) is amended by inserting after subsection (d) the following:</text> 
<quoted-block display-inline="no-display-inline" id="HF3224D54EFD441ACB254FEC3BABA2CCC" style="OLC"> 
<subsection id="H06A0596BB86449E48478457B58A48B1C"><enum>(e)</enum> 
<paragraph commented="no" display-inline="yes-display-inline" id="H7B601A38343448B2A983690DB94456BE"><enum>(1)</enum><text>Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of fentanyl-related substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.</text></paragraph> <paragraph id="HBBA2FE69881541C99498C924B61B005F" indent="up1"><enum>(2)</enum><text>In paragraph (1), the term <term>fentanyl-related substances</term> includes any substance that is structurally related to fentanyl by one or more of the following modifications:</text> 
<subparagraph id="H16D4C609FFCF48578FE427AF694F8F3E"><enum>(A)</enum><text>By replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle.</text></subparagraph> <subparagraph id="H32A30A3928FC498DA4EB4025FF08BEE5"><enum>(B)</enum><text>By substitution in or on the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or nitro groups.</text></subparagraph> 
<subparagraph id="H89397F1665A94782B75DCC1AF648FCCA"><enum>(C)</enum><text>By substitution in or on the piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, amino or nitro groups.</text></subparagraph> <subparagraph id="H84C4870535AD447C886060613FF4A358"><enum>(D)</enum><text>By replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle.</text></subparagraph> 
<subparagraph id="HD465471447EF456781EBFD34AEC479D0"><enum>(E)</enum><text>By replacement of the N-propionyl group by another acyl group.</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></section> <section id="H65E5517648BE4D5A820453DC1B3E1311"><enum>3.</enum><header>Penalties</header><text display-inline="no-display-inline">A fentanyl-related substance shall be treated as an analogue of N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide under section 401(b)(1) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/841">21 U.S.C. 841(b)(1)</external-xref>) and section 1010(b) of the Controlled Substances Import and Export Act (<external-xref legal-doc="usc" parsable-cite="usc/21/960">21 U.S.C. 960(b)</external-xref>) without requiring proof that a fentanyl-related substance meets the definition of a controlled substance analogue under section 102 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802</external-xref>). </text></section> 
<section id="H17616E5B237444DBB74EAB1295769970"><enum>4.</enum><header>Effective date</header><text display-inline="no-display-inline">This Act shall take effect one day after the date of enactment of this Act.</text></section> </legis-body></bill>

